KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Halozyme Therapeutics (HALO) Cost of Revenue (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Cost of Revenue for 16 consecutive years, with $78.8 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 87.3% to $78.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $228.8 million through Dec 2025, up 43.51% year-over-year, with the annual reading at $228.8 million for FY2025, 43.51% up from the prior year.
  • Cost of Revenue for Q4 2025 was $78.8 million at Halozyme Therapeutics, up from $55.2 million in the prior quarter.
  • The five-year high for Cost of Revenue was $78.8 million in Q4 2025, with the low at $15.9 million in Q1 2022.
  • Average Cost of Revenue over 5 years is $40.1 million, with a median of $42.1 million recorded in 2022.
  • The sharpest move saw Cost of Revenue soared 301.01% in 2021, then fell 20.9% in 2024.
  • Over 5 years, Cost of Revenue stood at $21.6 million in 2021, then skyrocketed by 95.12% to $42.1 million in 2022, then increased by 24.16% to $52.3 million in 2023, then fell by 19.59% to $42.1 million in 2024, then soared by 87.3% to $78.8 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $78.8 million, $55.2 million, and $46.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.